|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Commission and licensing fee income | |||||
| Total revenue | |||||
| Cost of sales (exclusive of depreciation and amortization) | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Change In Valuation of Contingent Payment Liability | |||||
| Impairment of intangibles | |||||
| Impairment of lease right-of-use asset and fixed assets | |||||
| Income from operations | |||||
| Gain on derivative | |||||
| Interest and other (expense) / income - net | |||||
| Income before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Non-Controlling Interest | |||||
| Total net income | |||||
| Less: net income attributable to noncontrolling interest | |||||
| Non-Controlling Interest | |||||
| Total less: net income attributable to noncontrolling interest | |||||
| Earnings Per Share | |||||
| Basic net income per share | |||||
| Diluted net income per share | |||||
| Basic weighted average common shares outstanding | |||||
| Effect of dilutive securities – options/restricted stock | |||||
| Diluted weighted average common shares outstanding | |||||
| Cash dividends declared per common share |
Loading...